United States · 
What does Age1 invest in?
Age1 invests most often at Series A (100% of the rounds on record), in sectors such as Longevity, Biotech and Therapeutics.
Age1 highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series A: 100% of its rounds
- 03
Led 1 rounds
What they do
age1 funds breakthrough longevity companies addressing the core challenges of the fieldFrom their own website
- Type
- VC firm
- Cheque size
- $500K – $4.0M as they say
- Stages
- Pre-seedSeedSeries A
- Sectors
- LongevityBiotechTherapeutics
- Based in
- San Francisco, United States
- Cold pitches
- Accepted
The record
Every round we can evidence, newest first1 appearances
- 2026
1 round
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration1 named
AJAlex James ColvilleManaging MemberiFiling they signed
We also hold 6 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
11 of 17 we have independently watched raise
ALX OncologyAerskaFauna BioGeneral ProximityLoyalMetacrineNewLimitReservoir NeuroscienceSkeletalisUnity BiotechnologyUntil LabsConception BioGeneral ControlGordian BioNavitorPrecision BioscienceScience Corporation
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.